// App-Quantinova.ai

1162 : Determination of Rivaroxaban in Urine Samples From Patients Undergoing Elective Hip- and Knee Replacement Surgery Using a Point of Care Method

Researchers

Presenter

  • Shanshan Du

Principal Investigators

  • Sandra Kraemer

  • Christina Giese

  • Astrid Schulze

  • Roland Kraemer

Medical Centers

  • Clinical Pharmacology, Medical Faculty Mannheim, Mannheim, Germany

  • Orthopedic Center, Medical Faculty Mannheim, Mannheim, Germany

  • Anorganic Chemical Institute, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • Xarelto

Outcome

  • N/A

Study Design

  • fixed dose

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved